You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《全日速報》恆指升643點; 恆生科技指數升191點 阿里巴巴升逾6% 騰訊升逾4% 美團升逾4% 騰訊、萬洲、翰森製藥、京東健康、紫金礦業創新高 成交暢旺
恆指全日收25,613點,升643點或2.6%。恆生科技指數報5,630點,升191點或3.5%。國指升233點或2.6%,報9,150點。大市成交額2,840.41億元。 活躍重磅股表現: 阿里巴巴(09988.HK) 收123.7元,上升6.1%; 騰訊(00700.HK) 收586元,上升4.7%,創新高; 美團(03690.HK) 收124.3元,上升4.1%; 小米集團(01810.HK) 收53.25元,上升3%; 港交所(00388.HK) 收439.8元,上升2.3%; 平安(02318.HK) 收56.8元,上升1.6%; 異動恆指及國指成份股: 石藥(01093.HK) 收10.72元,上升6.8%; 萬洲(00288.HK) 收8.36元,上升6.2%,創新高; 藥明康德(02359.HK) 收106.3元,上升6.2%; 翰森製藥(03692.HK) 收38.06元,上升5.4%,創新高; 網易(09999.HK) 收215.4元,上升5.4%; 舜宇(02382.HK) 收81.6元,上升5.4%; 阿里健康(00241.HK) 收5.14元,上升4.7%; 快手-W(01024.HK) 收74.95元,上升4.7%; 百濟神州(06160.HK) 收179.8元,上升4.7%; 創科(00669.HK) 收103.2元,上升4.5%; 藥明生物(02269.HK) 收30.8元,上升4.2%; 百度集團-SW(09888.HK) 收88.15元,上升4.1%; 京東集團(09618.HK) 收127.4元,上升3.8%; 京東健康(06618.HK) 收55.95元,上升3.8%,創新高; 周大福(01929.HK) 收14.26元,上升3.8%; 紫金礦業(02899.HK) 收23.7元,上升3.6%,創新高; 比亞迪(01211.HK) 收115元,上升3.3%; 理想汽車(02015.HK) 收97.15元,上升3.3%; 比亞迪電子(00285.HK) 收40.86元,上升3.1%; 友邦(01299.HK) 收76.4元,上升3%,創新高; 異動綜合中小型股: 閱文集團(00772.HK) 收37.32元,上升19.6%,創新高; FIT HON TENG(06088.HK) 收4.27元,上升11.8%,創新高; 丘鈦(01478.HK) 收15元,上升10.8%,創新高; 五礦資源(01208.HK) 收4.66元,上升10.4%,創新高; ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account